EMBC Stock Chart & Stats
$201.91
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range$201.91 - $250.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)0.00
Market Cap
$3.41B
Enterprise Value$1.70K
Total Cash (Recent Filing)$184.90M
Total Debt (Recent Filing)$1.36B
Price to Earnings (P/E)1.7
Beta0.09
Next Earnings
Aug 07, 2026EPS Estimate
4.66Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.91
Shares Outstanding59,327,680
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.42
Price to Book (P/B)-1.26
Price to Sales (P/S)0.76
P/FCF Ratio4.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$69.58Price Target Upside― Downside
Rating ConsensusModerate Sell
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EMBC FAQ
What was Embecta Corporation’s price range in the past 12 months?
Embecta Corporation lowest stock price was $201.91 and its highest was $250.00 in the past 12 months.
What is Embecta Corporation’s market cap?
Embecta Corporation’s market cap is $3.41B.
When is Embecta Corporation’s upcoming earnings report date?
Embecta Corporation’s upcoming earnings report date is Aug 07, 2026 which is in 12 days.
How were Embecta Corporation’s earnings last quarter?
Embecta Corporation released its earnings results on May 05, 2026. The company reported $4.727 earnings per share for the quarter, missing the consensus estimate of $7.301 by -$2.574.
Is Embecta Corporation overvalued?
According to Wall Street analysts Embecta Corporation’s price is currently Undervalued.
Does Embecta Corporation pay dividends?
Embecta Corporation does not currently pay dividends.
What is Embecta Corporation’s EPS estimate?
Embecta Corporation’s EPS estimate is 4.66.
How many shares outstanding does Embecta Corporation have?
Embecta Corporation has 59,327,680 shares outstanding.
What happened to Embecta Corporation’s price movement after its last earnings report?
Embecta Corporation reported an EPS of $4.727 in its last earnings report, missing expectations of $7.301. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Embecta Corporation?
Currently, no hedge funds are holding shares in MX:EMBC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Embecta Corporation Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$69.58 (― Downside)
$69.58 (― Downside)
Blogger Sentiment
Bearish
MX:EMBC Sentiment 70%
Sector Average 65%
Sector Average 65%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-69.88%
12-Months-Change
Fundamentals
Return on Equity
13.81%
Trailing 12-Months
Asset Growth
-8.11%
Trailing 12-Months
Company Description
Embecta Corporation
Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey. The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022.
EMBC Company Deck
EMBC Earnings Call
Q2 2026
0:00 / 0:00
EMBC Stock 12 Month Forecast
Average Price Target
$69.58